Nirmatrelvir during acute SARS-CoV-2 does not reduce risk for long COVID
Jan 05, 2024
No association was seen for rebound symptoms or test positivity with symptoms of long COVID.
Paxlovid not helpful for reducing most post-COVID-19 conditions
Oct 31, 2023
No differences were seen in most post-COVID-19 conditions examined individually or by organ system, apart from a lower combined risk for venous thromboembolism and pulmonary embolism.